312 related articles for article (PubMed ID: 25691119)
1. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
[TBL] [Abstract][Full Text] [Related]
2. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.
Mackey RH; Kuller LH; Deane KD; Walitt BT; Chang YF; Holers VM; Robinson WH; Tracy RP; Hlatky MA; Eaton CB; Liu S; Freiberg MS; Talabi MB; Schelbert EB; Moreland LW
Arthritis Rheumatol; 2015 Sep; 67(9):2311-22. PubMed ID: 25988241
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis.
Cacciapaglia F; Fornaro M; Venerito V; Perniola S; Urso L; Iannone F
Eur J Clin Invest; 2020 Dec; 50(12):e13343. PubMed ID: 32654116
[TBL] [Abstract][Full Text] [Related]
6. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.
Curtis JR; Xie F; Crowson CS; Sasso EH; Hitraya E; Chin CL; Bamford RD; Ben-Shachar R; Gutin A; Flake DD; Mabey B; Lanchbury JS
Arthritis Res Ther; 2020 Dec; 22(1):282. PubMed ID: 33276814
[TBL] [Abstract][Full Text] [Related]
7. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
[TBL] [Abstract][Full Text] [Related]
8. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.
Myasoedova E; Chandran A; Ilhan B; Major BT; Michet CJ; Matteson EL; Crowson CS
Ann Rheum Dis; 2016 Mar; 75(3):560-5. PubMed ID: 25637001
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
[TBL] [Abstract][Full Text] [Related]
10. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
11. Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
Arts EE; Fransen J; Den Broeder AA; van Riel PLCM; Popa CD
Ann Rheum Dis; 2017 Oct; 76(10):1693-1699. PubMed ID: 28606965
[TBL] [Abstract][Full Text] [Related]
12. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
[TBL] [Abstract][Full Text] [Related]
13. Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
Crowson CS; Rollefstad S; Kitas GD; van Riel PL; Gabriel SE; Semb AG;
PLoS One; 2017; 12(3):e0174656. PubMed ID: 28334012
[TBL] [Abstract][Full Text] [Related]
14. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
Crowson CS; Rollefstad S; Ikdahl E; Kitas GD; van Riel PLCM; Gabriel SE; Matteson EL; Kvien TK; Douglas K; Sandoo A; Arts E; Wållberg-Jonsson S; Innala L; Karpouzas G; Dessein PH; Tsang L; El-Gabalawy H; Hitchon C; Ramos VP; Yáñez IC; Sfikakis PP; Zampeli E; Gonzalez-Gay MA; Corrales A; Laar MV; Vonkeman HE; Meek I; Semb AG;
Ann Rheum Dis; 2018 Jan; 77(1):48-54. PubMed ID: 28877868
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors.
Arida A; Zampeli E; Konstantonis G; Fragiadaki K; Kitas GD; Protogerou AD; Sfikakis PP
Clin Rheumatol; 2015 May; 34(5):853-9. PubMed ID: 25754335
[TBL] [Abstract][Full Text] [Related]
16. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP;
Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956
[TBL] [Abstract][Full Text] [Related]
17. External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis.
Sasso EH; Mabey B; Flake DD; Hitraya E; Chin CL; Ben-Shachar R; Gutin A; Lanchbury JS; Curtis JR
PLoS One; 2024; 19(5):e0296459. PubMed ID: 38709770
[TBL] [Abstract][Full Text] [Related]
18. The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Lato V; Becciolini A; Favalli EG; Giovagnoni A
Swiss Med Wkly; 2018 Aug; 148():w14656. PubMed ID: 30141517
[TBL] [Abstract][Full Text] [Related]
19. Risk of Obstructive Sleep Apnea and Its Association with Cardiovascular and Noncardiac Vascular Risk in Patients with Rheumatoid Arthritis: A Population-based Study.
Wilton KM; Matteson EL; Crowson CS
J Rheumatol; 2018 Jan; 45(1):45-52. PubMed ID: 28765254
[TBL] [Abstract][Full Text] [Related]
20. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.
van Breukelen-van der Stoep DF; Zijlmans J; van Zeben D; Klop B; van de Geijn GJ; van der Meulen N; Hazes M; Birnie E; Castro Cabezas M
Scand J Rheumatol; 2015; 44(6):443-8. PubMed ID: 26169960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
